Literature DB >> 23375446

Retrospective group fusion similarity search based on eROCE evaluation metric.

Sorin I Avram1, Luminita Crisan, Alina Bora, Liliana M Pacureanu, Stefana Avram, Ludovic Kurunczi.   

Abstract

In this study, a simple evaluation metric, denoted as eROCE was proposed to measure the early enrichment of predictive methods. We demonstrated the superior robustness of eROCE compared to other known metrics throughout several active to inactive ratios ranging from 1:10 to 1:1000. Group fusion similarity search was investigated by varying 16 similarity coefficients, five molecular representations (binary and non-binary) and two group fusion rules using two reference structure set sizes. We used a dataset of 3478 actives and 43,938 inactive molecules and the enrichment was analyzed by means of eROCE. This retrospective study provides optimal similarity search parameters in the case of ALDH1A1 inhibitors.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23375446     DOI: 10.1016/j.bmc.2012.12.041

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Pharmacophore-based screening and drug repurposing exemplified on glycogen synthase kinase-3 inhibitors.

Authors:  Luminita Crisan; Sorin Avram; Liliana Pacureanu
Journal:  Mol Divers       Date:  2017-01-21       Impact factor: 2.943

2.  Extended many-item similarity indices for sets of nucleotide and protein sequences.

Authors:  Dávid Bajusz; Ramón Alain Miranda-Quintana; Anita Rácz; Károly Héberger
Journal:  Comput Struct Biotechnol J       Date:  2021-06-16       Impact factor: 7.271

3.  COX Inhibition Profile and Molecular Docking Studies of Some 2-(Trimethoxyphenyl)-Thiazoles.

Authors:  Smaranda Dafina Oniga; Liliana Pacureanu; Cristina Ioana Stoica; Mariana Doina Palage; Alexandra Crăciun; Laurentiu Răzvan Rusu; Elena-Luminita Crisan; Cătălin Araniciu
Journal:  Molecules       Date:  2017-09-09       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.